# FDA Inspection 769902 - Pfizer Inc - February 29, 2012

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/af1a2db8-2b6b-4969-aff6-449d72722778
Source feed: FDA_Inspections

> FDA Inspection 769902 for Pfizer Inc on February 29, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 769902
- Company Name: Pfizer Inc
- Inspection Date: 2012-02-29
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1101585 - 2019-08-20](https://www.keypedia.com/records/fda_inspections/pfizer-inc/e71f9a3e-9405-4af0-9320-2a3f8778d73a)
- [FDA Inspection 969406 - 2016-02-16](https://www.keypedia.com/records/fda_inspections/pfizer-inc/cbea359c-ea33-4443-8a23-f4a523038cac)
- [FDA Inspection 879922 - 2014-05-21](https://www.keypedia.com/records/fda_inspections/pfizer-inc/7fa35377-ca62-4df4-ba74-c696de5c2648)

Company: https://www.keypedia.com/companies/pfizer-inc/144866e0-8b03-436f-a174-9ae92a9c9fc5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c